» Articles » PMID: 30013457

It Is Time to Move Beyond the Linear No-Threshold Theory for Low-Dose Radiation Protection

Overview
Journal Dose Response
Publisher Sage Publications
Date 2018 Jul 18
PMID 30013457
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

The US Environmental Protection Agency (USEPA) is the primary federal agency responsible for promulgating regulations and policies to protect people and the environment from ionizing radiation. Currently, the USEPA uses the linear no-threshold (LNT) model to estimate cancer risks and determine cleanup levels in radiologically contaminated environments. The LNT model implies that there is no safe dose of ionizing radiation; however, adverse effects from low dose, low-dose rate (LDDR) exposures are not detectable. This article (1) provides the scientific basis for discontinuing use of the LNT model in LDDR radiation environments, (2) shows that there is no scientific consensus for using the LNT model, (3) identifies USEPA reliance on outdated scientific information, and (4) identifies regulatory reliance on incomplete evaluations of recent data contradicting the LNT. It is the time to reconsider the use of the LNT model in LDDR radiation environments. Incorporating the latest science into the regulatory process for risk assessment will (1) ensure science remains the foundation for decision making, (2) reduce unnecessary burdens of costly cleanups, (3) educate the public on the real effects of LDDR radiation exposures, and (4) harmonize government policies with the rest of the radiation scientific community.

Citing Articles

INWORKS and Hiroshima/Nagasaki Leukaemia Results.

Chaplin K Dose Response. 2024; 22(4):15593258241303476.

PMID: 39713752 PMC: 11660241. DOI: 10.1177/15593258241303476.


Health Effect of Low-Dose-Rate Irradiation with Cumulative Threshold Dose: A Promising Area to Explore in Nuclear Emergency and Environmental Contamination.

Tang F Cells. 2024; 13(18.

PMID: 39329705 PMC: 11429844. DOI: 10.3390/cells13181521.


Establishing a genomic radiation-age association for space exploration supplements lung disease differentiation.

Ruprecht N, Singhal S, Schaefer K, Gill J, Bansal B, Sens D Front Public Health. 2023; 11:1161124.

PMID: 37250098 PMC: 10213902. DOI: 10.3389/fpubh.2023.1161124.


The Future of Radioactive Medicine.

Sproull M, Wilson E, Miller R, Camphausen K Radiat Res. 2023; 200(1):80-91.

PMID: 37141143 PMC: 10466314. DOI: 10.1667/RADE-23-00031.1.


Performance Evaluation of Radiation-Shielding Materials and Process Technology for Manufacturing Skin Protection Cream.

Kim S Materials (Basel). 2023; 16(8).

PMID: 37109895 PMC: 10146880. DOI: 10.3390/ma16083059.


References
1.
Ozasa K, Shimizu Y, Suyama A, Kasagi F, Soda M, Grant E . Studies of the mortality of atomic bomb survivors, Report 14, 1950-2003: an overview of cancer and noncancer diseases. Radiat Res. 2011; 177(3):229-43. DOI: 10.1667/rr2629.1. View

2.
Schubauer-Berigan M, Leuraud K, Richardson D, Cardis E, Daniels R, Gillies M . INWORKS study: risk of leukaemia from protracted radiation exposure - Authors' reply. Lancet Haematol. 2015; 2(10):e405-6. DOI: 10.1016/S2352-3026(15)00201-X. View

3.
Krille L, Dreger S, Schindel R, Albrecht T, Asmussen M, Barkhausen J . Risk of cancer incidence before the age of 15 years after exposure to ionising radiation from computed tomography: results from a German cohort study. Radiat Environ Biophys. 2015; 54(1):1-12. DOI: 10.1007/s00411-014-0580-3. View

4.
Cohen B . The Puskin observation on smoking as a confounder in ecologic correlations of cancer mortality rates with average county radon levels. Health Phys. 2004; 86(2):203-4. DOI: 10.1097/00004032-200402000-00013. View

5.
Mossman K . Cancer complexity and radiation protection. Health Phys. 2014; 107(1):73-9. DOI: 10.1097/HP.0000000000000054. View